SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001390478-15-000012
Filing Date
2015-03-05
Accepted
2015-03-05 16:53:01
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K gale-20141231x10k.htm 10-K 2023739
2 EXHIBIT 23.1 gale-20141231xex231.htm EX-23.1 3087
3 EXHIBIT 23.2 gale-20141231xex232.htm EX-23.2 2922
4 EXHIBIT 31.1 gale-20141231xex311.htm EX-31.1 8158
5 EXHIBIT 31.2 gale-20141231xex312.htm EX-31.2 8171
6 EXHIBIT 32.1 gale-20141231xex321.htm EX-32.1 6882
13 performance2014.jpg GRAPHIC 104349
14 pipeline2015.jpg GRAPHIC 329005
  Complete submission text file 0001390478-15-000012.txt   12185584

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gale-20141231.xml EX-101.INS 1753211
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20141231.xsd EX-101.SCH 72428
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20141231_cal.xml EX-101.CAL 94306
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20141231_def.xml EX-101.DEF 255154
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20141231_lab.xml EX-101.LAB 816131
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20141231_pre.xml EX-101.PRE 438789
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 15677964
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences